Genomma Lab Internacional Valuation
Based on Macroaxis valuation methodology, the firm cannot be evaluated at this time. Genomma Lab Internacional regular Real Value cannot be determined due to lack of data. The prevalent price of Genomma Lab Internacional is $0.0. Our model calculates the value of Genomma Lab Internacional from evaluating the firm fundamentals such as Current Valuation of 1.09 B, return on asset of 0.0921, and Return On Equity of 0.13 as well as inspecting its technical indicators and probability of bankruptcy.
Genomma Lab Total Value Analysis
Genomma Lab Internacional is currently expected to have takeover price of 1.09 B with market capitalization of 973.77 M, debt of 3.83 B, and cash on hands of 1.3 B. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Genomma Lab fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.09 B | 973.77 M | 3.83 B | 1.3 B |
Genomma Lab Investor Information
About 29.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.38. Some equities with similar Price to Book (P/B) outperform the market in the long run. Genomma Lab Internacional last dividend was issued on the 9th of November 2022. The entity had 2:1 split on the 3rd of August 2010. Based on the measurements of operating efficiency obtained from Genomma Lab's historical financial statements, Genomma Lab Internacional is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Genomma Lab Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Genomma Lab has an asset utilization ratio of 71.89 percent. This implies that the Company is making $0.72 for each dollar of assets. An increasing asset utilization means that Genomma Lab Internacional is more efficient with each dollar of assets it utilizes for everyday operations.Genomma Lab Ownership Allocation
Genomma Lab Internacional has a total of 1 Billion outstanding shares. Genomma Lab secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.Genomma Lab Profitability Analysis
The company reported the revenue of 15.49 B. Net Income was 1.31 B with profit before overhead, payroll, taxes, and interest of 9.56 B.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Genomma Lab's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Genomma Lab and how it compares across the competition.
Genomma Lab Growth Indicators
Investing in growth stocks can be very risky. If the company such as Genomma Lab does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1 B | |
| Quarterly Earnings Growth Y O Y | 0.026 | |
| Forward Price Earnings | 7.6923 | |
| Retained Earnings | 9.4 B |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Consideration for investing in Genomma Pink Sheet
If you are still planning to invest in Genomma Lab Internacional check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Genomma Lab's history and understand the potential risks before investing.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |